Surmodics (SRDX) Competitors

Surmodics (NASDAQ:SRDX) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

Which has higher earnings and valuation, SRDX or ATRC?

Surmodics has higher earnings, but lower revenue than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Surmodics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surmodics	$126.08M	4.25	-$11.54M	-$1.23	-30.46
AtriCure	$465.31M	3.79	-$44.70M	-$0.77	-46.04

Is SRDX or ATRC more profitable?

AtriCure has a net margin of -7.27% compared to Surmodics' net margin of -14.59%. Surmodics' return on equity of -2.99% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surmodics	-14.59%	-2.99%	-1.99%
AtriCure	-7.27%	-4.20%	-3.19%

Do analysts recommend SRDX or ATRC?

Surmodics presently has a consensus price target of $43.00, suggesting a potential upside of 14.79%. AtriCure has a consensus price target of $50.89, suggesting a potential upside of 43.55%. Given AtriCure's stronger consensus rating and higher possible upside, analysts plainly believe AtriCure is more favorable than Surmodics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surmodics	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
AtriCure	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals & insiders have more ownership in SRDX or ATRC?

96.6% of Surmodics shares are held by institutional investors. Comparatively, 99.1% of AtriCure shares are held by institutional investors. 8.9% of Surmodics shares are held by insiders. Comparatively, 3.5% of AtriCure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media refer more to SRDX or ATRC?

In the previous week, Surmodics had 11 more articles in the media than AtriCure. MarketBeat recorded 20 mentions for Surmodics and 9 mentions for AtriCure. AtriCure's average media sentiment score of 0.97 beat Surmodics' score of 0.61 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surmodics	4 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, SRDX or ATRC?

Surmodics has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Comparatively, AtriCure has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500.

Summary

AtriCure beats Surmodics on 9 of the 16 factors compared between the two stocks.